Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ReLive Life Sciences is a biotechnology company specializing in regenerative medicine and stem cell-based therapies. The company focuses on developing and commercializing advanced cellular products for orthopedics, wound care, and aesthetic medicine. Their portfolio includes mesenchymal stem cell (MSC) therapies, exosome-based treatments, and platelet-rich plasma (PRP) solutions. ReLive operates with a focus on the Asia-Pacific region, providing clinical-grade regenerative solutions to healthcare providers. The company aims to bridge the gap between laboratory research and clinical application through its proprietary cell processing platforms.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ReLive Life Sciences.